Clinuvel Pharmaceuticals Ltd. earnings per share and revenue

CLVLF earnings per share for the last semiannual are 0.14 USD whereas the estimation was 0.18 USD which accounts for -17.65% surprise. Company revenue for the same period amounts to 21.96 M USD despite the estimated figure of 23.69 M USD. Estimated earnings per share for the next semiannual are 0.30 USD, and revenue is expected to reach 37.47 M USD. Also watch annual changes over time to get a bigger picture of CLVLF earnings per share and revenue dynamics.